Avanos Medical, Inc. (NYSE: AVNS) reported Q4 EPS of $0.46, $0.06 better than the analyst estimate of $0.40. Revenue for the quarter came in at $193 million versus the consensus estimate of $191.32 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2022 EPS of $1.55-$1.75, versus the consensus of $1.52. Avanos Medical, Inc. sees FY2022 revenue of $830-850 million, versus the consensus of $780 million.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.